Total Laryngectomy
11
2
3
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
18.2%
2 terminated out of 11 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
67%
4 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Gender Disparities in Voice Outcomes After Tracheoesophageal Puncture in Total Laryngectomy Patients (UC Davis)
Mechanical and Sensorial Training in the Olfactive Rehabilitation of Patients With Total Laryngectomy
Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis
Pre-operative Counselling in Laryngectomized Patients
Aortic Laryngeal Rehabilitation Graft
Effects of Propofol-dexmedetomidine on Immune Function in Patients With Cancer Larynx
ENTegral Artificial Larynx Clinical Trial
Long-term Clinical Feasibility of the New Indwelling Provox Vega 20 Voice Prosthesis
Laryngectomy Education
Long Term Use of the Provox Vega 22.5
Short-term Clinical Feasibility of the Provox XtraHMEs for Pulmonary Rehabilitation After Total Laryngectomy